115 related articles for article (PubMed ID: 10579919)
1. Signal transduction in the erythropoietin receptor system.
Wojchowski DM; Gregory RC; Miller CP; Pandit AK; Pircher TJ
Exp Cell Res; 1999 Nov; 253(1):143-56. PubMed ID: 10579919
[TBL] [Abstract][Full Text] [Related]
2. Signal transduction in the erythropoietin receptor system.
Wojchowski DM; He TC
Stem Cells; 1993 Sep; 11(5):381-92. PubMed ID: 8241949
[TBL] [Abstract][Full Text] [Related]
3. "Benign erythrocytosis" and other familial and congenital polycythemias.
Prchal JT; Sokol L
Eur J Haematol; 1996 Oct; 57(4):263-8. PubMed ID: 8982288
[TBL] [Abstract][Full Text] [Related]
4. Subtraction cloning and initial characterization of novel epo-immediate response genes.
Gregory RC; Lord KA; Panek LB; Gaines P; Dillon SB; Wojchowski DM
Cytokine; 2000 Jul; 12(7):845-57. PubMed ID: 10880228
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin receptor Y479 couples to ERK1/2 activation via recruitment of phospholipase Cgamma.
Halupa A; Chohan M; Stickle NH; Beattie BK; Miller BA; Barber DL
Exp Cell Res; 2005 Sep; 309(1):1-11. PubMed ID: 15953601
[TBL] [Abstract][Full Text] [Related]
6. Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera.
Ugo V; Marzac C; Teyssandier I; Larbret F; Lécluse Y; Debili N; Vainchenker W; Casadevall N
Exp Hematol; 2004 Feb; 32(2):179-87. PubMed ID: 15102479
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of erythropoietin action.
Koury MJ; Bondurant MC
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):20-3. PubMed ID: 1656733
[TBL] [Abstract][Full Text] [Related]
8. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
9. Role of c-Kit and erythropoietin receptor in erythropoiesis.
Munugalavadla V; Kapur R
Crit Rev Oncol Hematol; 2005 Apr; 54(1):63-75. PubMed ID: 15780908
[TBL] [Abstract][Full Text] [Related]
10. Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells.
Lifshitz L; Prutchi-Sagiv S; Avneon M; Gassmann M; Mittelman M; Neumann D
Mol Immunol; 2009 Feb; 46(4):713-21. PubMed ID: 19027957
[TBL] [Abstract][Full Text] [Related]
11. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
Um M; Gross AW; Lodish HF
Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.
Feldman L; Wang Y; Rhim JS; Bhattacharya N; Loda M; Sytkowski AJ
Prostate; 2006 Feb; 66(2):135-45. PubMed ID: 16161153
[TBL] [Abstract][Full Text] [Related]
13. Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis.
von Lindern M; Deiner EM; Dolznig H; Parren-Van Amelsvoort M; Hayman MJ; Mullner EW; Beug H
Oncogene; 2001 Jun; 20(28):3651-64. PubMed ID: 11439328
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
[TBL] [Abstract][Full Text] [Related]
15. The erythropoietin receptor and its expression in tumor cells and other tissues.
Farrell F; Lee A
Oncologist; 2004; 9 Suppl 5():18-30. PubMed ID: 15591419
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin biology in cancer.
Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
[TBL] [Abstract][Full Text] [Related]
17. Lovastatin suppresses erythropoietin receptor surface expression through dual inhibition of glycosylation and geranylgeranylation.
Hamadmad SN; Hohl RJ
Biochem Pharmacol; 2007 Aug; 74(4):590-600. PubMed ID: 17586475
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin and its receptor in breast cancer: putting together the pieces of the puzzle.
Mannello F; Tonti GA
Oncologist; 2008 Jul; 13(7):761-8. PubMed ID: 18596367
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma multiforme cells: expression of erythropoietin receptor and response to erythropoietin.
Yin D; Kawabata H; Tcherniamtchouk O; Huynh T; Black KL; Koeffler HP
Int J Oncol; 2007 Nov; 31(5):1193-8. PubMed ID: 17912447
[TBL] [Abstract][Full Text] [Related]
20. Impaired erythropoiesis after haemorrhagic shock in mice is associated with erythroid progenitor apoptosis in vivo.
Robinson Y; Matenov A; Tschöke SK; Weimann A; Oberholzer A; Ertel W; Hostmann A
Acta Anaesthesiol Scand; 2008 May; 52(5):605-13. PubMed ID: 18419713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
